对甲苯腺苷蛋氨酸

   浙江汇力药业有限公司创建于1981年，专注药用空心胶囊研发制造四十余年。公司现拥有5500平方米10万级洁净车间，配备18条智能化生产线，年产胶囊100亿粒，产品涵盖明胶胶囊、植物胶囊、无二氧化钛胶囊及无环氧乙烷灭菌胶囊四大系列，通过欧盟GMP等国际认证。2023年，集团旗下浙江汇力胶囊有限公司在杭州经济技术开发区启动总投资8亿元的智能植物胶囊基地项目，打造覆盖全球区域的现代化植物胶囊生产中心及大健康产品一体化OEM服务平台。企业依托自主创新研发体系，将绿色生产工艺与智能化生产深度融合，为全球客户提供创新型解决方案。    Zhejiang Huili Pharmaceutical Co., Ltd., established in 1981, has specialized in the R&D and manufacturing of pharmaceutical hollow capsules for over four decades. The company operates a 5,500-square-meter 100,000-class clean workshop equipped with 18 intelligent production lines, achieving an annual production capacity of 10 billion capsules. Its product portfolio spans four major series: gelatin capsules, plant-based capsules, titanium dioxide-free capsules, and ethylene oxide-free sterilized capsules, all certified under international standards including EU GMP.    In 2023, its subsidiary Zhejiang Huili Capsule Co., Ltd. launched an RMB 800 million intelligent plant-based capsule production base project in Hangzhou Economic and Technological Development Zone, aiming to build a world-leading modern plant-based capsule manufacturing hub and an integrated OEM service platform for comprehensive health products.    By leveraging its independent R&D system, the company seamlessly integrates green production processes with intelligent manufacturing to provide innovative solutions for global clients. This initiative reinforces its commitment to advancing pharmaceutical excipients and health product innovation while driving sustainable industrial transformation.